Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 2Gynecologic 1

Conditions

Anemia, Refractory, with Excess of Blasts 255Myelodysplastic Syndromes 228Leukemia, Myeloid, Acute 228Anemia 212Leukemia 205Precursor Cell Lymphoblastic Leukemia-Lymphoma 168Leukemia, Myelomonocytic, Chronic 145Neoplasms 142Leukemia, Lymphocytic, Chronic, B-Cell 116Myeloproliferative Disorders 114Multiple Myeloma 113Lymphoma, Non-Hodgkin 105Thrombocytopenia 100Lymphoma 98Hodgkin Disease 91Anemia, Refractory 81Venous Thromboembolism 77Congenital Abnormalities 77Anemia, Aplastic 77Primary Myelofibrosis 76Lymphoma, Follicular 73Leukemia, Myeloid, Chronic-Phase 70Blast Crisis 67Leukemia, Myelogenous, Chronic, BCR-ABL Positive 65Leukemia, Myeloid, Accelerated Phase 64Lymphoma, Mantle-Cell 63Febrile Neutropenia 62Myelodysplastic-Myeloproliferative Diseases 58Hematologic Neoplasms 56Burkitt Lymphoma 56

Interventions

ferrous sulfate 1ferric gluconate 1Standard of Care 1Ferric Oxide, Saccharated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Iron Deficiencies × Classical hematology × Clear all
NCT03933813 2023-01-05

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

University of Wisconsin, Madison

Phase 1/2 Terminated
9 enrolled
Classical hematologyGynecologic

Carcinoma, Ovarian Epithelial, Iron Deficiencies, Anemia, Ovarian Neoplasms, Anemia, Iron-Deficiency

NCT00224068 2012-03-02

Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy

Watson Pharmaceuticals

Phase 4 Completed
180 enrolled
Classical hematology

Iron Deficiencies, Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡